University Contacts
University of Illinois at Urbana-Champaign Nathan Hoffmann, Director Office of Technology Management [email protected] otm.illinois.edu
Laura Frerichs, Director University of Illinois Research Park [email protected] researchpark.illinois.edu University Breakthroughs
Northwestern University Powering Change Alicia Loffler, Associate Vice President Research/Associate Provost for Innovation and New Ventures Innovation and New Ventures Office [email protected] invo.northwestern.edu
University of Chicago Eric Ginsburg, Associate Director, Technology Commercialization Polsky Center for Innovation and Entrepreneurship [email protected] polsky.uchicago.edu
University of Illinois at Chicago Suseelan Pookote, Director Office of Technology Management [email protected] otm.uic.edu
Illinois Institute of Technology Catherine E. Vorwald, Associate Vice Provost Office of Technology Development [email protected] research.iit.edu/technology-development
Hosted by AGENDAMORNING 8:30 Check-In Check-In
Welcome & Opening Remarks: Mark Harris, President Welcome & Opening Remarks: Mark Harris, President 9:00 & CEO Illinois Science & Technology Coalition & CEO Illinois Science & Technology Coalition Network Security, Mobile Computing Breakthroughs in Oncology & Artificial Intelligence
Wen-Mei Hwu (University of Illinois at Urbana-Champaign): Game Changing AI 9:20 - Jeffrey Hubbell (University of Chicago): Tumor-targeting Immunotherapies to 9:20 - and Block Chain Systems at the IBM-Illinois Center for Cognitive Computing Systems 9:40 Enhance Antitumor Efficacy and Reduce Adverse Events 9:40 Research (C3SR) 9:40 - Arnon Lavie (University of Illinois at Chicago): Structure-Based Design of Novel 9:40 - Aleksandar Kuzmanovic (Northwestern University): bloXroute: Scaling Blockchains 10:00 Therapeutic Agents by Prodrug Development and Enzyme Modification 10:00 by 1000X and Beyond 10:00 - Stephen Boppart (University of Illinois at Urbana-Champaign): Stain-Free Slide-Free 10:00 - Brighten Godfrey (University of Illinois at Urbana-Champaign): Continuous Network 10:20 Histopathology Platform with Biomarkers of Cancer 10:20 Verification and Congestion Control 10:20 - Vadim Backman (Northwestern University): Chromatin Regulation to Fight Resistance 10:20 - Heather Zheng (University of Chicago): Vulnerabilities in Social and Mobile Networks 10:40 in Cancer Chemotherapy 10:40 10:40 - Melody Swartz (University of Chicago): Lymphangiogenesis for Immunomodulation in 10:40 - Romit Roy Choudhury (University of Illinois at Urbana-Champaign): New Techniques 11:00 Cancer Therapy 11:00 in Mobile Computing and Their Applications
11:00 - Break 11:20 Break Frontiers in Neuroscience Materials by Design
11:20 - 11:20 - Mark Hersam (Northwestern University): Introducing the Memtransistor: John Rogers (Northwestern University): Skin-Interfaced Wearables for Clinical Health 11:40 11:40 A Potential Foundational Circuit Element for Neuromorphic Computing 11:40 - Richard Kraig (University of Chicago): Intranasal IGF-1 for the Treatment 11:40 - Paul Braun (University of Illinois at Urbana-Champaign): Paradigm Changing Materials 12:00 of Migraine 12:00 for Energy Storage 12:00 - Rashid Bashir (University of Illinois at Urbana-Champaign): Analysis of Blood and 12:00 - Dmitri Talapin (University of Chicago): Direct Optical Patterning of Inorganic Materials 12:20 Tissue Using Chip Scale Sensors 12:20 12:20 - 12:20 - Vikas Berry (University of Illinois at Chicago): Graphene and Other Nanostructures for Terry Vanden Hoek (University of Illinois at Chicago): Peptide Memetics of Cooling 12:40 12:40 Applications from Energy to Medicine AFTERNOON
12:40AGENDA - Lunch Lunch 1:40 Breakthroughs in Oncology Data Analytics & Robotics
John Katzenellenbogen (University of Illinois at Urbana-Champaign): Inhibitors 1:40 - 1:40 - Michael Franklin (University of Chicago): Data Science, Systems, Distributed of FOXM1, a Key Driver of Many Cancers, and Orally Active Antiestrogens Effective in 2:00 2:00 Computing, and Big Data Recurrent, Endocrine-Resistant Breast Cancers 2:00 - Jennifer Wu (Northwestern University): Restoring Anti-Tumor Immunity: Targeting the 2:00 - Matthew Spenko (Illinois Institute of Technology): Robots That Climb 2:20 Immunosuppressive Molecule sMIC 2:20 and Perch 2:20 - Lev Becker (University of Chicago): A Novel Biologic for the Treatment of Many 2:20 - Kaiyu Guan (University of Illinois at Urbana-Champaign): Ecohydrology 2:40 Types of Cancer 2:40 and Remote Sensing 2:40 - Gregory Thatcher (University of Illinois at Chicago): Synthesis of Novel Compounds 2:40 - Kris Hammond (Northwestern University): Humanizing Data Through Natural 3:00 and Biomimetics for Probing of Biological Systems 3:00 Language Generation 3:00 - Ernst Lengyel (University of Chicago): CT45A Antigens for T-cell-based 3:00 - Mani Golparvar-Fard (University of Illinois at Urbana-Champaign): Visual Progress 3:20 Immunotherapies for Ovarian Cancer 3:20 Monitoring and Risk Management for Construction Projects
3:20 - Break Break 3:40 Frontiers in Neuroscience Social Good & Sustainability
Rayid Ghani (University of Chicago) : Using Data Science and AI to Tackle Social 3:40 - Maria Siemionow (University of Illinois at Chicago): Novel Chimeric Cell Technology 3:40 - Issues in Public Health, Education, Criminal Justice, and Public Safety in the US as well 4:00 for Treatment of Rare Diseases 4:00 as Globally 4:00 - Joseph Moskal (Northwestern University): Glycogenes: Novel targets for Brain Tumor 4:00 - Amin Kohjin-Salehi (University of Illinois at Chicago): CO2 Conversion 4:20 Therapeutic Development 4:20 to Energy Rich Chemicals Using Inexpensive and Earth Abundant Catalytic System 4:20 - Euan Parnell (Northwestern University): Targeting Synaptic GEFs in Alzheimer’s 4:20 - Sammy Tin (Illinois Institute of Technology): Design Approaches for Advanced 4:40 Disease and Dementia 4:40 Materials and Processes 4:40 - Mary Jo LaDu (University of Illinois at Chicago): A Novel Alzheimer’s Disease 4:40 - Christopher Wolverton (Northwestern University): The Virtual Materials Laboratory 5:00 Biomarker in Human Plasma 5:00
5:00 - Networking Networking 6:00 Aptinyx Clarix Imaging
A clinical-stage biopharmaceutical company A medical device company developing focused on the discovery and development innovative imaging hardware and software of transformative therapies for challenging to provide workflow-friendly solutions for This list includes start-ups affiliated with neurologic disorders. Aptinyx has a proven comprehensive surgical oncology. Clarix Imaging UPSfaculty presenters as well as those that platform for discovering compounds that work enables multidisciplinary clinical teams to will be available during the networking through a novel mechanism: modulation of improve the accuracy and efficiency in surgical reception ( denotes companies with NMDA receptors to enhance communication management of cancer. The company’s first table space). between neural cells. product is a compact, real-time, high-resolution 3D specimen imaging system for intra-operative Northwestern surgical margin assessment and for guiding American BioOptics Founder: Joseph Moskal gross pathologic evaluation. aptinyx.com Revolutionizing cancer screening with the University of Chicago introduction of the InPoint™ System, the first Founder: Xiaochuan Pan personalized cancer risk assessment to provide immediate and accurate results to identify high- bloXroute Labs risk patients that need further evaluation. Resolves the information propagation The first application of use is for colorectal ClostraBio bottleneck, allowing all nodes to maintain the cancer (CRC). consensus over the state of the blockchain, ClostraBio is a preclinical-stage pharmaceutical even when mining thousands of transactions company creating new medicines to prevent Northwestern per second, on-chain. bloXroute is a scalability life-threatening allergic reactions to food Founder: Vadim Backman solution which allows all cryptocurrencies and related diseases resulting from gut americanbiooptics.com and blockchains to scale to thousands of microbiome disruption. The company uses its transactions per second (TPS) on-chain, without capabilities to study the microbiome to identify changing their protocol. metabolites that are missing or depleted Anokion when the gut microbiome is disrupted, then Northwestern replace those metabolites using its propriety Anokion harnesses the power of natural immune Founder: Aleksandar Kuzmanovic polymer delivery platform to restore gut barrier equilibrium to develop solutions for antigen- bloxroute.com function. ClostraBio is applying this strategy to specific immune tolerance. The company develop drug candidates for food allergy and is focused on applying its antigen-specific inflammatory bowel diseases. immune tolerance technology to reduce the immunogenicity of therapeutic proteins and University of Chicago treat autoimmune diseases. Co-Founders: Cathryn Nagler & Jeffrey Hubbell Co-Founders: Melody Swartz & Jeffrey clostrabio.com Hubbell anokion.com START Diagnostic Photonics Dystrogen Therapeutics Enzyme By Design Fertility Basics
Diagnostic Photonics provides hand-held, Dystrogen Therapeutics is a clinical stage Enzyme by Design focuses on providing Fertility Basics has developed a user-friendly high resolution optical and computed imaging regenerative medicine company focusing on safer cancer therapeutics for indications in App which accesses a complex algorithm for systems. The Foresee (4C) Imaging System rare diseases. The company is currently testing which there is a large unmet clinical need. the diagnosis and treatment of an individual’s provides a real-time, intraoperative view into the Dystrophin Expressing Chimeric (DEC) cell Current indications the company is targeting infertility. The science behind this App is backed structure of human tissue during cancer surgery therapy for Duchenne Muscular Dystrophy. include hematological malignancies with the by 20 years of clinical practice. 80% of the to ensure all tumor is removed, and reinforces DECs work by combining a malfunctioning cell potential to also treat certain solid tumors couples who have used the science behind this clinicians’ confidence in their therapeutic of the Duchenne patient with a working cell through decreasing the toxicity of these App have become pregnant within a year and interventional decisions. from a healthy donor. Dystrogen has created chemotherapeutics. Enzyme by Design closely have not needed to undergo costly in-vitro dystrophin-producing cells that can engraft analyzes the 3-D structure of proteins and, fertilization (IVF). The App has been designed University of Illinois at Urbana- inside the patient’s muscles and increase their through careful structure-based design, with three interfaces for use by couples, Champaign dystrophin levels. introduces minor mutations at the amino acid physicians, and medical students. The App is Founder: Stephen Boppart level that affects the enzymatic activity so as to now available on the UIC App store and is being diagnosticphotonics.com University of Illinois at Chicago achieve the desired effect. further beta tested by UI Health physicians. Founder: Maria Siemionow dystrogen.com University of Illinois at Chicago University of Illinois at Chicago Dimension Inx Founder: Arnon Lavie Founder: John Holden enzymebydesign.com With its unique and proprietary 3D-Painting EarthSense technologies, Dimension Inx is transforming the Ikaika Therapeutics landscape of medical and nonmedical industries EarthSense creates compact, autonomous, and Epicore BioSystems with innovative, practical, scalable, functional teachable robots for agricultural applications, Ikaika is developing biologics to target genetic and user-friendly materials. The company opening new possibilities in crop breeding, Epicore Biosystems creates soft microfluidics modifiers of human muscular dystrophy (MD). offers an extensive range of advanced material agricultural product development, product devices that harvest and route sweat from LTBP4, a latent binding protein, has been products (e.g. synthetic and naturally derived testing, and crop research. It improves the skin pores. These novel biosensing devices identified as a modifier of the most common biomaterials, metals and alloys, advanced speed, accuracy, and cost of in-field data monitor human physiology to optimize athletic and devastating form of human MD, Duchenne carbon and non-carbon materials, and simple collection and real-time analytics. Its TerraSentia performance and health. Muscular Dystrophy. LTBP4’s hinge region after and complex ceramics) compatible with robot carries a variety of sensors to collect data proteolysis can lead to TGFb & myostatin release advanced manufacturing processes, including on traits including plant health, physiology, and Northwestern & University of Illinois which modify muscular dystrophy. Ikaika is 3D-printing as well as final manufactured stress response, among others. EarthSense also at Urbana-Champaign developing high affinity anti-LTBP4 antibodies product and service solutions. has developed a cloud-based platform to teach Co-Founders: John Rogers to stabilize its hinge region, thereby limiting the robot to automatically measure a variety of & Roozbeh Ghaffari TGFb and myostatin activation. Ikaika has Northwestern key traits. identified additional genetic regions that modify Co-Founders: Ramille Shah MD and cardiomyopathy. & Adam Jakus University of Illinois at Urbana- dimensioninx.com Champaign Northwestern Co-Founders: Girish Chowdhary & Co-Founders: Beth McNally Chinmay Soman & Alexis Demonbreun earthsense.co InnSight Technology IntelinAir Laurel Therapeutics LiveBx
InnSight Technology is primarily focused IntelinAir is a precision agriculture company Laurel Therapeutics is focused on developing Stain-free slide-free molecular histopathology on the development and commercialization empowering farmers by providing them with a seven amino acid peptide inhibitor of from a novel laser light source and pulse of OcuCheck, a novel, hand-held, point-of- easy-to-use and actionable expert analysis of angiogenesis and vascular permeability, shaping techniques that captures dynamic service biosensor device for detecting anterior high-resolution images from frequent overflights referred to as EBIN. The EBIN peptide has cellular and molecular events as new diagnostic ophthalmic injuries. OcuCheck can quantify of their fields. Farmers use IntelinAir to make shown remarkable promise in a rodent model biomarkers of disease. LiveBx (Living Biopsy) specific biomarkers in the tear that result from data-driven decisions to improve operational of laser-induced choroidal neovascularization technology acquires real-time images from fresh micro leaks from corneal wounds. This is the efficiency, yields, and profitability. (CNV), which mimics angiogenic eye diseases, resected or in-vivo tissues without the need for first device of its kind to provide an accurate, including age-related macular degeneration and stains or dyes, changing the way that tissue is objective measurement that can be used to University of Illinois at Urbana- diabetic retinopathy. The peptide was effective assessed microscopically for disease detection assess the integrity of the corneal surface after Champaign in this model whether administered as an intra- and diagnosis. surgery or trauma. The device is easy-to-use, Founder: Naira Hovakimyan vitreal injection, or very importantly, as a topical provides immediate results, and is a game- intelinair.com eye-drop. It also is effective in animal models of University of Illinois at Urbana- changer for use in eye clinics and by health acute lung injury, sepsis, allergy, and cancer. Champaign personnel. Founder: Stephen Boppart Kanyos Bio University of Illinois at Chicago University of Illinois at Urbana- Founder: Yulia Komarova Champaign Kanyos Bio aims to develop antigen-specific MulticoreWare Co-Founders: Dipanjan Pan, immune tolerance technology for two specific Leanne Labriola autoimmune indications, type-1 diabetes and LifeFoundry A worldwide team of scientists and innsightech.com celiac disease. entrepreneurs focused on developing LifeFoundry’s platform, BioFoundry, enables technologies for video codecs, media analytics, Founder: Jeffrey Hubbell on-demand, high-throughput, and precision and autonomous vehicles. By leveraging Inspirit IoT kanyos.com engineering of biological systems for practical combined skills in high performance and applications, including synthesis of high- heterogeneous computing, machine learning Providing hardware accelerator solutions value chemicals, drug development & waste and neural networks, computer vision, and coupled with an advanced high-level synthesis Kuros Biosciences treatment. It is the world’s first fully-automated compiler technologies, MulticoreWare is and machine-learning optimization toolkit and highly-versatile robotic platform for uniquely positioned to advance the state-of-the- to enable smart IoT applications. Inspirit IoT Kuros has spent more than a decade refining synthetic biology applications. LifeFoundry art in focus areas including autonomous vehicle delivers a compelling channel and customer technologies that instruct the body to form partners with clients to expedite their R&D research, media analytics, machine learning, and experience in markets where performance, bone using targeted and controlled mechanisms and achieve significant cost reduction, and neural networks. power, and time-to-market are a mission or of action. is currently helping Fortune 500 companies regulatory imperative. construct & evaluate industrial microorganisms University of Illinois at Urbana- Founder: Jeffrey Hubbell to optimize their fermentation processes. Champaign University of Illinois at Urbana- kuros.ch Founder: Wen-Mei Hwu Champaign University of Illinois at Urbana- multicorewareinc.com Founder: Deming Chen Champaign Advisor: Wen-Mei Hwu Founders: Sam Hamedi Rad & Ran Chao inspirit-iot.com life-foundry.com NanoCytomics NowPow Pax Neuroscience PhotoniCare
Dedicated to enabling dramatic improvements NowPow offers a multi-sided referral platform Pax Neuroscience, a clinical diagnostics Improving medical outcomes through innovative in cancer survival rates. The company’s that seamlessly supports all participants in company, is focused on development and applications of light-based point-of-care imaging proprietary PWS technology platform is the referral process by building and managing commercialization of blood tests based on technologies at the front-line of healthcare. designed to provide highly accurate, low-cost, community resource networks. NowPow protein biomarkers for depression and for PhotoniCare’s first product, the hand-held non-invasive testing that will revolutionize the partners with health systems, health plans, and antidepressant response. These diagnostics ClearView imaging tool, uses optical coherence risk stratification of patients, helping physicians community-based organizations to provide allow patients and physicians to make better tomography to see through the eardrum to identify people that are likely to benefit from social needs identification, screenings, referral individualized treatment decisions and shorten accurately diagnose ear infections and improve gold-standard procedures to diagnose cancer matching technology, closed loop referrals, and tremendously the time lag between initiation of the management of this prevalent disease. as early as possible, when treatments are most outcome tracking. antidepressant treatment and knowledge about likely to be effective. whether a given drug has therapeutic efficacy University of Illinois at Urbana- University of Chicago (currently 6-8 weeks for each drug). There is no Champaign Northwestern Founder: Stacy Lindau other product that can both confirm a physician’s Co-Founders: Stephen Boppart Founder: Vadim Backman nowpow.com diagnosis of depression and predict treatment & Ryan Shelton nano-cytomics.com response. Pax’s lead product is a simple blood photoni.care test that offers objective biological evidence of Onchilles Pharma depression and rapid indication of treatment Narrative Science response, derived from physiological changes Prenosis Onchilles Pharma Inc. is a preclinical- stage specific to clinical depression. Humanizing data like never before, with oncology company developing novel biologics Developing precision medicine tools including a technology that interprets your data, then for the treatment of cancer based on University of Illinois at Chicago point-of-care device for blood cell and protein transforms it into insightful, natural language discoveries. Its biologics have a unique method Founder: Mark Rasenick measurements, and machine learning and data narratives at unprecedented speed and scale. of action that will enable the development paxneuroscience.com analytics for stratification of sepsis. Turn your data into an actionable, powerful of medicines for a variety of cancers that asset you can use to make better decisions, selectively kill cancer cells without damaging University of Illinois at Urbana- improve interactions with customers, and normal cells and tissues. Phi Optics Champaign empower your employees. Co-Founders: Rashid Bashir University of Chicago Phi Optics is developing the next generation of & Bobby Reddy Northwestern, Co-Founders: Founder: Lev Becker optical imaging systems through its Quantitative prenosis.co Kris Hammond & Larry Birnbaum Phase Imaging Platform. The company’s narrativescience.com technology platform uses standard tools and processes and combines the performance of Preora Healthcare traditional modalities of a light microscope with NeuroLux the real-time 3D topography capabilities of QPI. Preora’s PWS Nanocytology™ platform detects This combination offers a significant advantage early cellular changes at the nanoscale level that Developing discovery tools for neuroscience. for applications that require low-cost, fast, and cause cancer, and the corresponding impact on NeuroLux’s breakthrough technologies for accurate imaging of nanostructures. treatments for cancer. The platform is composed optogenetics are lightweight, battery-free, of three core technologies, from sample preparation implantable, and ultraminituarized. University of Illinois at Urbana- to analysis, that will increase the depth and Champaign quality of clinically-relevant information. University of Illinois at Urbana- Founder: Gabriel Popescu Champaign, Co-Founders: phioptics.com Northwestern John Rogers & Anthony Banks Founder: Vadim Backman neurolux.org preorahealthcare.com Psyonic Radius Sense Photonics Sonica
Psyonic is dedicated to creating robotic medical Committed to developing and commercializing Building the next generation of LiDAR systems Sonica is developing a next-generation, devices that push the boundaries of human- innovative endocrine therapeutics in the for autonomous vehicles, UAVs, industrial proprietary sensor technology paired with machine interfaces while being accessible areas of osteoporosis and oncology. Radius’ automation, and many other applications. Sense advanced analytics that allows for multi-modal to those who need them worldwide. The lead product, TYMLOS® (abaloparatide) Photonic’s core technology enables a simple, sensing in a discrete, comfortable form factor. company’s first product is an advanced bionic injection, was approved by the U.S. Food and high-performance, solid state solution with The technology has broad implications across hand for people with upper limb amputations. Drug Administration for the treatment of no moving parts that can meet the rigorous military, consumer and medical applications- This hand is the fastest on the market, easy to postmenopausal women with osteoporosis at performance, reliability, and cost requirements -Sonica has validated the technology in control, provides touch feedback, and is robust high risk for fracture. of the automotive industry. collaboration with leading academic institutions to impacts. in its first target area: stroke rehabilitation. University of Illinois at Urbana- Northwestern University of Illinois at Urbana- Champaign Founder: John Rogers Northwestern Champaign Founder: John Katzenellenbogen sense-photonics.com Founder: John Rogers Founder: Aadeel Akhtar radiuspharm.com psyonic.co Seurat Therapeutics Synaural Reconstruct QuesTek Seurat Therapeutics is innovating migraine care Synaural is an early stage neurotechnology Provides a command center of 3D timelines for and accelerating the translation of scientific company which offers a patented technology QuesTek provides innovative materials solutions. construction projects that track visual progress, discoveries into life-changing medicine. By with proven capability to objectively measure It designs and develops new advanced materials labor productivity, and predictive analytics that replicating environmental enrichment, a brain health and function. This technology in less than 50% of the time and at less than empower executives and their project teams to naturally occuring phenomenon, in a therapeutic can be leveraged by professionals to inform 30% of the cost of traditional empirical methods. stay on time and on budget. approach, the company is working to stop the screening and diagnosis of neurological By leveraging its proprietary Materials by migraines and prevent them in the future. conditions through an individual’s lifecycle. Design technology, the current focus is in high- University of Illinois at Urbana- Their treatment philosophy stems from a belief performance steels and other alloys. Champaign that novel neurotherapeutics based on EE can Northwestern Co-Founders: Mani Golparvar-Fard improve brain health. Founder: Nina Kraus Northwestern & Derek Hoiem synaural.com Founder: Gregory Olson reconstructinc.com University of Chicago questek.com Founder: Richard Kraig seurat-therapeutics.com RMarkBio
rMark Bio’s industry-leading AI solution understands the real-time business strategies of R&D, Medical Affairs, Marketing, and Commercial to provide field representatives with clear and concise ‘next best decisions’ that remove inefficiencies and increase ROI for thought leader engagements.
University of Chicago Founder: Lev Becker rmarkbio.com Tanvas Veriflow Wearifi Xerion Advanced Battery
Tanvas uses electrostatics to control friction Developing continuous network verification, Developing lightweight, wearable near-field Developing battery technologies based and create virtual touch. The applications for which builds a deep understanding of network communication technology with potential uses upon StructurePore™, a nanostructured, this technology are endless – feel the edges infrastructure to model and mathematically ranging from patient monitoring to consumer 3-D conductive foam, and DirectPlate™, a of keys, the snap of a toggle switch, the swipe verify network-wide policies, providing transaction payments. manufacturing method which directly deposits of a turned page, the direction and magnitude intuitive, actionable insight. Veriflow is the first the battery materials via electroplating. of impacts in a game. For anyone who wants networking company to leverage this technology University of Illinois at Urbana- Together, these technologies form a platform to elevate, deliver or participate in a more to eliminate network outages and vulnerabilities Champaign & Northwestern that supports building batteries engaging and complete touchscreen experience, which can lead to astronomical losses. Co-Founders: John Rogers with custom properties such as high power, Tanvas provides a touchable canvas. Their & Anthony Banks high energy, fast charge, and reduced cost. programmable tools allow OEMs, agencies and University of Illinois at Urbana- developers to imagine and create an infinite Champaign University of Illinois at Urbana- number of holistic and integrated experiences Co-Founders: Brighten Godfrey X-Celeprint Champaign on any touch display. & Matthew Caesar Founder: Paul Braun veriflow.net Developing and licensing patented Micro- xerionbattery.com Northwestern Transfer Printing (μTP) and related technology. Co-Founders: Edward Colgate μTP is a cost-effective and scalable & Michael Peshkin Vivotronix manufacturing platform for integrating tanvas.co microscale devices such as lasers, LEDs or Vivotronix has developed non-obtrusive integrated circuits onto non-native substrates. wearable cardiovascular monitors that can A wholly-owned subsidiary of XTRION N.V. Trillbit be applied as a chest patch, chest band, or integrated into sportswear. The core technology University of Illinois at Urbana- Trillbit is creating proximity intelligence using is clinically-validated sensors and sensor Champaign sound. Trillbit’s cross-platform and zero fusion algorithms with predictive analytics to Founder: John Rogers deployment cost solution can convert any estimate important hemodynamic parameters x-celeprint.com speaker and microphone into a secure data noninvasively and continuously from optical transfer device. Trillbit is pursuing secure near pulse wave analysis. The monitored and field communication applications including an reported physiological parameters and indices alternative channel for IoT device and a location include blood pressure, cardiac output, energy intelligence platform which can serve as a expenditure, metabolic indices, vascular broader secure cyber-physical system. Using stiffness, and cardiovascular load. University of Illinois technology, Trillbit has also created a data privacy product: A device that University of Illinois at Chicago can stop any recording with a microphone thus Founder: Shane Phillips making an area secure from eavesdropping/ recording.
University of Illinois at Urbana- Champaign Technology Advisor: Romit Roy Choudhury trillbit.com UNIVERSITY BREAK- THROUGHS POWERING CHANGE